Members |
targetComponentId |
urofollitropin 150 enheter, pulver till injektionsvätska, lösning, ampull |
Product containing only urofollitropin (medicinal product) |
urofollitropin 75 IE, pulver och vätska till injektionslösning, ampull |
Product containing only urofollitropin (medicinal product) |
urofollitropin 75 IE, pulver till injektionsvätska, lösning, ampull |
Product containing only urofollitropin (medicinal product) |
urofollitropin 75 IE, pulver till injektionsvätska, ampull |
Urofollitropin 150 unit/mL solution for injection |
urokinas 250 000 IE, pulver till injektionsvätska, flaska |
Product containing only urokinase (medicinal product) |
urokinas 50 000 enheter/ml, injektionsvätska, lösning, flaska |
Urokinase 50000 unit/mL solution for injection |
uroporfyrinogensyntas |
Hydroxymethylbilane synthase |
Uroporphyrinogen-1 synthase |
Hydroxymethylbilane synthase |
Urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
urticaria pigmentosa |
Cutaneous mastocytosis (disorder) |
urticaria pigmentosa |
Cutaneous mastocytosis (morphologic abnormality) |
Urticaria pigmentosa, diffuse erythrodermic type |
Diffuse erythrodermic mastocytosis (disorder) |
urticaria pigmentosa, makulopapulös typ |
Cutaneous mastocytosis (disorder) |
urticaria pigmentosa, multipla knutor och/eller plack |
Cutaneous mastocytosis (disorder) |
Urticaria pigmentosa, solitary cutaneous nodule |
Solitary cutaneous mastocytoma (disorder) |
Urticaria pigmentosa, telangiectasia macularis eruptiva perstans |
Telangiectasia macularis eruptiva perstans |
går till prostituerade |
Client of prostitutes |
Using interatrial baffle |
Repair - action |
ustekinumab 90 mg/ml, injektionsvätska |
Product containing only ustekinumab (medicinal product) |
fynd som rör TNM-stadieindelning av tumör i livmoderhalsen |
American Joint Committee on Cancer allowable value |
Uterine incoordination |
Dyscoordinate labor |
ärrbildning i livmodern från tidigare kirurgisk åtgärd under graviditet, förlossning och puerperium med prenatal komplikation |
Uterine scar from previous surgery affecting pregnancy |
fynd som rör TNM-stadieindelning av uveamelanom |
American Joint Committee on Cancer allowable value |
V - volt |
volt (qualifier value) |
V-Y-operation av ektropion |
Repair of ectropion of skin of eyelid using local V-Y advancement flap (procedure) |
V-Y-operation av läpp |
Reconstruction of skin of lip using local V-Y advancement flap |
V-Y operation av hud och subkutan vävnad utan transplantation |
Reconstruction of skin using local V-Y advancement flap (procedure) |
Vabras kyrett |
Curette |
Vaccination required |
Requires vaccination (finding) |
vaccination nödvändig |
Requires vaccination (finding) |
Vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) |
COVID-19 vaccine |
vaccin som endast innehåller antigen från humant papillomvirus 9 |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
vaccin som endast innehåller antigen från levande försvagat humant poliovirus, serotyp 1, 2 och 3, parenteral läkemedelsform |
Inactivated whole Human poliovirus antigen only vaccine product |
Vagal bradycardia |
Vagal autonomic bradycardia |
fynd som rör TNM-stadieindelning av tumör i vagina |
American Joint Committee on Cancer allowable value |
Vaginal outlet |
Vaginal introitus structure |
Vaginal ulcertion |
Vaginal ulcer |
Valacyclovir hydrochloride 1g caplet |
Valaciclovir (as valaciclovir hydrochloride) 1 g oral tablet |
valganciklovir 50 mg/ml, pulver till oral lösning |
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
natriumvalproat 100 mg/ml, injektionsvätska, lösning |
Product containing precisely valproic acid 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumvalproat 250 mg/5 ml, sirap |
Valproic acid 50 mg/mL oral solution |
natriumvalproat 500 mg, pulver till injektionsvätska, flaska |
Valproic acid only product in parenteral dose form |
valproinsyra 250 mg/5 ml, sirap |
Valproic acid 50 mg/mL oral solution |
vankomycin 1 g, pulver för beredning av injektionsvätska |
Product containing only vancomycin (medicinal product) |
vankomycinhydroklorid 10 g, pulver till infusionsvätska, lösning, flaska |
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Vancomycin hydrochloride 1g/bot powder |
Product containing only vancomycin (medicinal product) |
Vancomycin hydrochloride 500mg injection |
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
vankomycinhydroklorid 750 mg, pulver till infusionsvätska, lösning |
Vancomycin only product in parenteral dose form |
Vardenafil hydrochloride 10 mg tablet |
Vardenafil (as vardenafil hydrochloride) 10 mg oral tablet |
vardenafilhydroklorid 10 mg, munsönderfallande tablett |
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet |
Vardenafil hydrochloride 2.5 mg tablet |
Vardenafil (as vardenafil hydrochloride) 2.5 mg oral tablet |
Vardenafil hydrochloride 20 mg tablet |
Product containing precisely vardenafil (as vardenafil hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Vardenafil hydrochloride 5 mg tablet |
Vardenafil (as vardenafil hydrochloride) 5 mg oral tablet |
immunglobulin varicella-zoster 125 IE, pulver till injektionsvätska, flaska |
Varicella-zoster virus antibody 104 unit/mL solution for injection |
Vascular disorder of iris AND/OR ciliary body |
Disorder of uveal tract |
Vascular procedures on axilla |
Vascular procedure on axilla (procedure) |
vaskulariserad revbenslambå |
Bone flap |
Vasodilator antihypertensive drug allergy |
Allergy to drug |
Vasopressin 20unt/mL injection |
Antidiuretic hormone 20 unit/mL solution for injection |
vasopressin 20 enheter/ml, injektionsvätska, lösning, flaska 0,5 ml |
Antidiuretic hormone 20 unit/mL solution for injection |
vasopressin 20 enheter/ml, injektionsvätska, lösning, flaska 10 ml |
Antidiuretic hormone 20 unit/mL solution for injection |
vasopressin 20 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Antidiuretic hormone 20 unit/mL solution for injection |
Vasorrhaphy |
Suture of laceration of vas deferens |
Vatikanstaten |
Holy See |
Vectorcardiogram with ECG |
Electrocardiogram with vectorcardiogram |
vekuroniumbromid 4 mg, pulver till injektionsvätska, flaska |
Product containing only vecuronium in parenteral dose form (medicinal product form) |
Veillonella alcalescens |
Veillonella parvula (organism) |
Veillonella alcalescens ss alcalescens |
Veillonella parvula (organism) |
Veillonella alcalescens ss criceti |
Veillonella criceti |
Veillonella alcalescens ss dispar |
Veillonella dispar |
Veillonella alcalescens ss ratii |
Veillonella ratti |
velagluceras alfa 200 enheter, frystorkat pulver till injektionsvätska |
Product containing only velaglucerase alfa (medicinal product) |
velofarnyngeal insufficiens orsakad av kluven gom |
Incomplete closure of velopharyngeal apparatus due to cleft palate |
venlafaxinhydroklorid 37,5 mg, kapsel med modifierad frisättning |
Venlafaxine only product in oral dose form |
venlafaxinhydroklorid 37,5 mg, depåkapsel |
Venlafaxine only product in oral dose form |
Ventral surface of tongue |
Structure of inferior surface of tongue |
ventral tunglambå |
Flap (substance) |
kammarseptumdefekt med åt vänster felinriktat utloppsseptum som överrider aortaklaff |
Ventricular septal defect with posterior malaligned outlet septum with overriding aortic valve (disorder) |
kammarseptumdefekt med åt vänster felinriktat utloppsseptum som överrider pulmonalklaff |
Ventricular septal defect with posterior malaligned outlet septum with overriding pulmonary valve (disorder) |
kammarseptumdefekt med åt höger felinriktat utloppsseptum som överrider aortaklaff |
Ventricular septal defect with anterior malaligned outlet septum with overriding aortic valve (disorder) |
kammarseptumdefekt med åt höger felinriktat utloppsseptum som överrider pulmonalklaff |
Ventricular septal defect with anterior malaligned outlet septum with overriding pulmonary valve (disorder) |
verapamilhydroklorid 100 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 100 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 100 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 180 mg, tablett med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 180 mg, depåtablett |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 180 mg, tablett |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 200 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 200 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 200 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 300 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 300 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 300 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 360 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 360 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 360 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 400 mg, tablett med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
verapamilhydroklorid 400 mg, depåtablett |
Product containing only verapamil in oral dose form (medicinal product form) |
muntlig rapport |
Verbal report (record artifact) |
Vernix caseosa |
Vernix caseosa (substance) |
Verruca plana |
Plane wart |